ALA 3.70% 14.0¢ arovella therapeutics limited

between now and the AGM, page-49

  1. 180 Posts.
    lightbulb Created with Sketch. 96
    Totally agree CBD and that’s what’s so scary now. We can’t land deals and those that we do are small. 5 years off meaningful royalties, 2+ billion shares With only just over a year of cash.
    How the hell did we get here?
    Management have been so wrong on all accounts.
    -Artimist - continual delays and stuff ups
    -BP wasn’t meant to be of any concern
    -Buying the new product range a few years ago and yet no formulations completed? Where was Sudas due diligence on how concrete the results were.
    -try to develop 003 and failed.
    -Heard nothing new in over a year on the hydrotrope system
    -tried selling formulations that weren’t ready and failed
    -can’t even land codevelopments in a timely manner
    - now onto trying to get lucky with 005 and 018.
    Luck is all we have left because I don’t see a bright future with Suda management the way things stand.

    [email protected]
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
14.0¢
Change
0.005(3.70%)
Mkt cap ! $147.2M
Open High Low Value Volume
13.5¢ 14.5¢ 13.5¢ $174.0K 1.245M

Buyers (Bids)

No. Vol. Price($)
2 61995 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
14.5¢ 183155 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.